<DOC>
	<DOCNO>NCT01179893</DOCNO>
	<brief_summary>Immunomodulation effective treating patient myasthenia gravis ( MG ) , prior study adequately define plasma exchange ( PLEX ) superior intravenous immunoglobulin ( IVIG ) treatment myasthenia gravis . This study aim determine PLEX superior IVIG treatment patient myasthenia gravis . Patients MG require immunomodulation randomize IVIG PLEX treat full course immunomodulation . The quantitative myasthenia gravis score ( QMGS ) evaluate primary efficacy parameter day 14 determine PLEX superior IVIG .</brief_summary>
	<brief_title>Intravenous Immunoglobulin Plasma Exchange Myasthenia Gravis</brief_title>
	<detailed_description />
	<mesh_term>Muscle Weakness</mesh_term>
	<mesh_term>Myasthenia Gravis</mesh_term>
	<mesh_term>Immunoglobulins , Intravenous</mesh_term>
	<mesh_term>gamma-Globulins</mesh_term>
	<mesh_term>Rho ( D ) Immune Globulin</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>&gt; 18 year old diagnosis moderatesevere MG ( define Quantitative Myasthenia Gravis Score QMGS &gt; 10.5 ) worsen weakness require change therapy judge neuromuscular expert Worsening weakness secondary concurrent medication ( e.g . Aminoglycosides ) Worsening weakness secondary infection Change corticosteroid dosage 2 week prior screen Other disorder cause weakness fatigue Known absolute IgA deficiency ( risk anaphylactic reaction IVIG ) History anaphylaxis severe systemic response IVIG albumin Pregnancy breastfeed Active renal failure precluding volume IVIG ( risk volume overload IVIG ) judge investigator Clinically significant cardiac disease preclude IVIG volume judge investigator Known hyperviscosity hypercoaguable state ( risk stroke IVIG ) Known coagulopathy bleeding On another current study medication protocol within 4 week screen Patients know refractory status either IVIG PLEX Poorly control severe hypertension ( exacerbation IVIG ) Patient refuse treatment either IVIG PLEX Patient refuse followup electrophysiological study Patient unable unwilling give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Myasthenia Gravis</keyword>
	<keyword>IVIG</keyword>
	<keyword>PLEX</keyword>
</DOC>